Morgan Stanley began coverage on Jardine Matheson, a company whose stock ratings and price targets are aggregated by MarketBeat.
6 reports, 2 independent
Updated Oct 14
Gone quiet
- Reports
- 6
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley began coverage on Jardine Matheson, a company whose stock ratings and price targets are aggregated by MarketBeat.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Morgan Stanley began coverage on Jardine Matheson, with MarketBeat providing average ratings and price targets.1 source
Morgan Stanley began coverage on Jardine Matheson, with MarketBeat aggregating ratings.1 source
Keep exploring
Part of
Analyst reports are affecting stock price targets for various companies, with company data being summarized on financial blogs.Also in this story
- Jefferies Financial Group restated its buy rating on Paylocity, while Truist Financial cut its target price.
- Financial firms including Bank of America, Morgan Stanley, and Truist Financial adjusted price targets and ratings for Somnigroup International Inc.
- Truist Financial issued a buy rating for a company, with MarketBeat providing average rating data.
- Analyst firms provided research reports and aggregated market data for Sensata Technologies.
The entities involved
-
Jardine Matheson
British conglomerate that incorporated in Bermuda and headquartered in Hong Kong
Nothing else this week.
-
Morgan Stanley
U.S. investment bank
-
MarketBeat
American personal finance blog
Related events
- Jefferies Financial Group began coverage, Morgan Stanley set a high price target, and Keefe, Bruyette & Woods increased price objectives, with MarketBeat reporting the average stock rating.
- MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
- MarketBeat provided average ratings and target prices, while Jefferies Financial Group began coverage with a buy rating for Crane NXT.
- Morgan Stanley started coverage on Versant (VSNT) shares on November 3, 2026.
- MarketBeat provided stock average ratings while Leerink Partners upgraded and Barclays raised its price objective for Summit Therapeutics.